Sr. R&D Project Manger
OtherHybridCambridge3 days ago
Company identity and hiring signals verified from public source listings
Observed daily snapshots
Latest: 146 roles
Observed active listings increased from 78 to 146 across 16 snapshot days. Missing days are left as gaps and are not estimated.
| Date | Active listings |
|---|---|
| 2026-09-05 | 78 |
| 2026-09-06 | 132 |
| 2026-09-07 | 132 |
| 2026-09-08 | 132 |
| 2026-09-09 | 133 |
| 2026-09-10 | 135 |
| 2026-09-12 | 134 |
| 2026-09-14 | 133 |
| 2026-09-26 | 138 |
| 2026-10-02 | 139 |
| 2026-10-09 | 140 |
| 2026-10-13 | 137 |
| 2026-10-16 | 138 |
| 2026-10-19 | 140 |
| 2026-10-22 | 141 |
| 2026-10-25 | 146 |
Listing recency
Source observation shows when Base Career last saw listings at their source. It does not mean every listing was revalidated within the last 24 hours.
Based on n=146 classified listings
Based on n=146 classified listings
Based on n=118 classified listings
Based on n=146 classified listings
| Seniority | Median range | Sample |
|---|---|---|
| Director | USD 188K–USD 259K / yearly | n=33 |
| Senior | USD 165K–USD 221K / yearly | n=28 |
| Manager | USD 121K–USD 162K / yearly | n=9 |
| Lead | USD 162K–USD 223K / yearly | n=7 |
| Mid | USD 180K–USD 248K / yearly | n=7 |
Verified active listings
OtherHybridCambridge3 days ago
MarketingHybridCambridge3 days ago
OtherOnsiteCambridge3 days ago
HrRemoteUSA3 days ago
DataHybridCambridge3 days ago
OtherOnsiteQuébec4 days ago
OperationsHybridCambridge4 days ago
HealthcareHybridTorontoCAD 58K+ / yearly5 days ago
HealthcareHybridCambridge5 days ago
FinanceHybridToronto1 weeks ago
OtherHybridTorontoCAD 58K+ / yearly1 weeks ago
HealthcareHybridCambridge1 weeks ago
SoftwareHybridCambridge1 weeks ago
HealthcareHybridCambridge1 weeks ago
OtherOnsiteCambridge1 weeks ago
HealthcareHybridCambridge1 weeks ago
OtherHybridCambridge1 weeks ago
OperationsHybridCambridge1 weeks ago
MarketingHybridCambridge1 weeks ago
OtherOnsiteLittle Rock1 weeks ago
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.